Faculty Information |
|
Article types | Original article |
Language | English |
Refereed paper | Not refereed |
Title | Real-world effectiveness and safety analysis of carfilzomib-lenalidomide-dexamethasone and carfilzomib-dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis |
Journal | Formal name:Therapeutic Advances in Hematology Abbreviation:Ther Adv hematol |
Domestic / Foregin | Foregin |
Volume, Number, Page | 24(13),pp.20406207221104584-20406207221104584 |
Papers・Author | Onda Y, Kanda J, Kaneko H, Shimura Y, Fuchida SI, Nakaya A, Itou T, Yamamura R, Tanaka H, Shibayama H, Shimazu Y, Uchiyama H, Yoshihara S, Adachi Y, Matsuda M, Hanamoto H, Uoshima N, Kosugi S, Ohta K, Yagi H, Kanakura Y, Matsumura I, Hino M, Nomura S, Shimazaki C, Takaori-Kondo A, Kuroda J; Kansai Myeloma Forum. |
Publication date | 2022/01 |